期刊文献+

狼疮样抗凝物质对复发性流产患者血栓前状态的影响 被引量:6

The influence of lupus anticoagulant on prethrombotic state in patients with recurrent spontaneous abortion
原文传递
导出
摘要 目的:探讨狼疮样抗凝物质(LA)对复发性流产(RSA)患者血栓前状态的影响。方法:测定110例RSA患者(RSA组)和102例正常生育期妇女(对照组)的LA比值(LAR)、D二聚体(D-D)、凝血酶原时间(PT)、活化部分凝血活酶时间、纤维蛋白原(FIB)和血小板聚集试验(PAgT)。结果:与对照组比较,RSA组的LAR、D-D、FIB和PAgT增高,PT缩短,差别有统计学意义(P均<0.05);以超过对照组(x±s)为阳性,RSA患者中的LAR、D-D及PAgT各指标阳性率明显高于FIB阳性率和PT阳性率。结论:RSA患者LAR的增高与血栓前状态指标的变化相平行,RSA血栓前状态的发生或发展与LA有关;LAR可作为RSA血栓前状态的监测指标之一。 Objective:To investigate the influence of lupus anticoagulant (LA) on prethrombotic state in patients with recurrent spontaneous abortion (RSA). Methods: 110 patients with RSA (RSA group) and 102 healthy women (control group) were selected in the study. LA ratio( LAR), the level of D -dimer (D -D), prothrombin time (PT), activated partial thromboplastin time, fihrinogen (FIB) and platelet aggregation test (PAgT) were de- termined. Results: As compared with those in control group, the levels of LAR, D - D, FIB and PAgT in RSA group increased, while the level of PT was shorten. These differences had statistical significance ( P 〈 0.05 ). The values of LAR, D - D, FIB and PAgT greater than x+ s and the value of PT lower than x ± s of control group were considered as positive. The positive rates of LAR, D - D and PAgT were higher obviously than those of FIB and PT in patients with RSA. Conclusion: The increase of LAR and the change of prethrombotic state parameters in pa- tients with RSA are at equal pace. The development of prethrombotic state in RSA is associated with LA. The LAR may be one of monitoring markers to judgc prcthrombotic state i, parle,its with RSA.
出处 《中国卫生检验杂志》 北大核心 2012年第10期2354-2355,2359,共3页 Chinese Journal of Health Laboratory Technology
基金 温州市科学技术局资助项目(Y20110235)
关键词 狼疮凝固抑制物 复发性流产 血液凝固 血栓前状态 Lupus anticoagulant Recurrent spontaneous abortion Blood coagulation Prethrombotic state
  • 相关文献

参考文献9

二级参考文献54

  • 1徐成伟,姜翠英,徐永萍,王振先,陈颖洁,韩梅,王正起.妊娠高血压综合征患者血栓前状态的研究[J].山东大学学报(医学版),2005,43(2):163-165. 被引量:19
  • 2徐亮,林其德,汪希鹏,赵爱民.个体化免疫抑制-抗凝疗法在抗心磷脂抗体阳性复发性流产患者治疗中的应用[J].中国实用妇科与产科杂志,2006,22(9):666-668. 被引量:42
  • 3[1]Ruddy S,Edward DH,Clement BSK et al.Textbook of Rheumatology[M]//Michael DL.Anfiphospholipid Antibody Syndrome.7th ed.北京:人民卫生出版社,2002:1145-1152.
  • 4[3]Robertsen B,Greaves M.Anfiphospholipid syndrome:an evolving story[J].Blood Rev,2006,20(4):201-212.
  • 5[4]Vermylen J,Carreras LO,Arnout J.Attempts to make sense of the antiphospholipid syndrome[J].J Thromb Haemost,2007,5(1):1-4.
  • 6[5]Oriel TL.Thrombosis and the antiphospholipid syndrome[M].Hematology.American Society of Hematology Education Program Book,2005:462-468.
  • 7[6]de Groot PG,Derksen RH.Pathophysiology of antiphospholipid antibodies[J].Neth J Med,2004,62(8):267-272.
  • 8[7]Galli M,Luciani D,Bertolini G,et al.Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome:a systematic review of the literature[J].Blood,2003,101(5):1827-1832.
  • 9[8]Yasuda S,Atsumi T,leko M,et al.Nicked beta2-glycoprotein Ⅰ:a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis[J].Blood,2004,103(10):3766-3772.
  • 10[9]Zhang J,McCrae KR.Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein Ⅰ antibodies[J].Blood,2005,105(5):1964-1969.

共引文献179

同被引文献44

  • 1刘玉昆,王蕴慧,刘颖琳,张睿,张建平.低分子肝素治疗不明原因复发性自然流产57例分析[J].中华临床医师杂志(电子版),2011,5(16):4916-4918. 被引量:32
  • 2张建平,吴晓霞.低分子肝素在复发性流产中的应用[J].中国处方药,2006,5(9):34-36. 被引量:13
  • 3张建平,饶群仙.低分子肝素治疗血栓前状态所致习惯性早期流产[J].中国处方药,2007(3):68-69. 被引量:3
  • 4刘宗花,王谢桐.低分子肝素治疗自身免疫型复发性流产的作用机制及安全性[J].山东医药,2007,47(20):114-115. 被引量:42
  • 5Martinelli J, Ruggenenti P, Cetin I. Heparin in pregnant women with previous placenta - mediated pregnancy complications : a prospective, randomized, multicenter, controlled clinical trial [ J ]. Blood, 2012, 119(14) :3269 -3275.
  • 6Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in preg- nancy[ J ]. Lancet,2010,375 (9713) :500 - 512.
  • 7PeRker CM, Lockwood CJ. Thromboembolie disorders [ M ]//Gabbe SG, Niebyl JR, Simpson JL, et al. Obstetrics: normal and problem pregnaneies. 5 th ed. Philadelphia: Churchill Livingstone, 2007 : 1064 - 1076.
  • 8Pratip C,Sayani B,Piyali S,et al. Aspirin and low- molecular weight heparin combination therapy effectivelyprevents recurrent miscarriage in hyperhomocysteinemic women[J]. Plos One, 2013,8 (9) : 741-745.
  • 9Fouda UM,Sayed AM,Ramadan DI,et al. Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recur- rent abortion secondary to antiphospholipid syndrome [J]. Journal of Obstetrics and Gynaecology, 2010,30 (8) : 842- 846.
  • 10De Vries JIP,Van Pampus MG,Hague WM,et al. Low- molecular-weight heparin added to aspirin in the preven- tion of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia:The FRUIT-RCT[J]. Journal of Thrombosis and Haemostasis, 2012,10 ( I ) : 64-72.

引证文献6

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部